Journal
ADVANCED SYNTHESIS & CATALYSIS
Volume 355, Issue 13, Pages 2538-2543Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adsc.201300554
Keywords
asymmetric synthesis; catalyst design; heterogeneous catalysis; Michael addition; warfarin
Categories
Funding
- Program for Changjiang Scholars and Innovative Research Team in Chinese Universities [IRT0980]
- National Natural Science Foundation of China [21036006, 21272214]
- Zhejiang Leading Team of Science and Technology Innovation [2009R50020]
Ask authors/readers for more resources
A novel chiral metal-organic framework (MOF) organocatalyst has been developed, based on readily available MIL-101 and the chiral primary diamine (1R,2R)-1,2-diphenylethylenediamine, by the post-synthetic modification. Over the developed chiral heterogeneous catalyst the asymmetric synthesis of (S)-warfarin with high enantioselectivity can be fulfilled on a gram-scale (2.8g) with excellent yield (92%) at low cost, making the synthesis method an ideal alternative to existing methods.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available